World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries.

In developing countries, H. pylori infection is a public health issue. The high prevalence of the infection means that public health interventions may be required. Therapeutic vaccination is probably the only strategy that would make a decisive difference in the prevalence and incidence of H. pylori throughout the world. The short-term approach, however – provided that resources allow for this – would be a test-and-treat strategy for those who are at risk for PUD or gastric cancer and for those with troublesome dyspepsia. Note by Prof. Barry Marshall, Nobel Laureate, Helicobacter Research Laboratory, University of Western Australia, Perth, Australia